Open randomized comparison of different itraconazole regimens for the treatment of onychomycosis

Journal of Dermatological Treatment

Volumn 10, Issue 4, 1999, Pages 245-249

  Shemer, A ^a   Nathansohn, Nir ^a   Kaplan, B ^a   Gilat, D ^a   Newman, N ^a   Trau, H ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Continuous treatment; Itraconazole; Onychomycosis; Pulse therapy

Indexed keywords

ITRACONAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHYTE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIVER FUNCTION TEST; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAIL DISEASE; NONHUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; RANDOMIZED CONTROLLED TRIAL; TOE;

EID: 0033388150     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639909056039     Document Type: Article

References (19)

1. Roberts DT, Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey. Br J Dermatol (1992) 126 (Suppl 39): 23-7.
2. Andre J, Achten G, Onychomycosis. Int J Dermatol (1987) 26: 481-90.
3. Ramesr V, Ready B, Singh R, Onychomycosis. Int J Dermatol (1983) 22: 148-52.
4. Hay RJ, Clayton YM, Griffith W, A comparative double-blind study of ketoconazol and griseofulvin in dermatophytosis. Br J Dermatol (1985) 112: 691-6.
5. Lake-Bakaar G, Scheuer PJ, Sherlock S, Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J (1987) 294: 419-22.
6. Brusko CS, Marten JT, Ketoconazole hepatotoxicity in a patient treated for environmental illness and systemic candidiasis. Drug Intell Clin Pharm (1991) 25: 1321-5.
7. Knight TE. Shikuma CY, Knight J, Ketoconazole-induced fulminant hepatitis necessitating liver transplantation [see comments]. J Am Acad Dermatol (1991) 25 (2 Pt 2): 398-400.
8. Bercoff E, Bernuau J, Degott C, Ketoconazole-induced fulminant hepatitis. Gut (1985) 26: 636-8.
9. Stricker B, Blok A, Bronkhorst FB, Ketoconazole-associated hepatic injury: A clinicopathologic study of 55 cases. J Hepatol (1986) 3: 399-406.
10. Jannsen P, Symoens J, Hepatic reactions during ketoconazole treatment. Am J Med (1983) 74: 80-5.
11. Espinel-Ingroff A, Shadomy S, Gebhart RJ, In vitro studies with R51.211 (itraconazole). Antimicrobial Agents Chemother (1986) 26: 5-9.
12. Nebert DW, Gonzales FJ, Cytochrome P-450 gene expression and regulation. Trends Pharmacol Sci (1985) 160: 25-30.
13. Meinhof BW, Kinetics and spectrum of activity of oral antifungals: The therapeutic implications. J Am Acad Dermatol (1993) 29: 537-41.
14. De Doncker P, Gupta AD, Marynissen G, Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview. J Am Acad Dermatol (1997) 37: 969-74.
15. Matthien L, De Doncker P, Cannenbergh G, Itraconazole penetrates the nail via the nail matrix and the nail bed: An investigation in onychomycosis. Clin Exp Dermatol (1991) 16: 374-6.
16. De Doncker P, Decroix J, Pierard GE, Antifungal pulse therapy for onychomycosis. Arch Dermatol (1996) 132: 34-41.
17. Cannenbergh G, Degreef H, Heykants J, Pharmacokinetic profile of orally administered itraconazole on human skin. J Am Acad Dermatol (1988) 18: 263-268.
18. Willemsen M, De Doncker P, Willems J, Post-treatment itraconazole levels in the nail. J Am Acad Dermatol (1992) 26: 731-5.
19. Gupta AK, Groen K, Woestenborghs R, De Doncker P, Itraconazole pulse therapy is effective in the treatment of Majocchi's granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis Clin Exp Dermatol (1998) 23(3): 103-8.